Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia

被引：0
|
作者：
Brittany Knick Ragon
Courtney D. DiNardo
机构：
[1] The Levine Cancer Institute,Department of Hematologic Oncology and Blood Disorders
[2] Carolinas HealthCare System,Department of Leukemia
[3] The University of Texas MD Anderson Cancer Center,undefined
来源：
Current Hematologic Malignancy Reports | 2017年 / 12卷
关键词：
IDH1; IDH2; AML; Novel therapeutics; Differentiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：537 / 546
页数：9
相关论文
共 50 条
  • [21] IDH1 and IDH2 Mutations in Gliomas
    Ducray, Francois
    Marie, Yannick
    Sanson, Marc
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2248 - 2249
  • [22] IDH1 and IDH2 Mutations in Gliomas
    Cohen, Adam L.
    Holmen, Sheri L.
    Colman, Howard
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (05)
  • [23] IDH1 and IDH2 Mutations in Gliomas
    Yan, Hai
    Parsons, D. Williams
    Jin, Genglin
    McLendon, Roger
    Rasheed, B. Ahmed
    Yuan, Weishi
    Kos, Ivan
    Batinic-Haberle, Ines
    Jones, Sian
    Riggins, Gregory J.
    Friedman, Henry
    Friedman, Allan
    Reardon, David
    Herndon, James
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Vogelstein, Bert
    Bigner, Darell D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08): : 765 - 773
  • [24] IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
    Petrova, Lucie
    Vrbacky, Filip
    Lanska, Miriam
    Zavrelova, Alzbeta
    Zak, Pavel
    Hrochova, Katerina
    CLINICAL BIOCHEMISTRY, 2018, 61 : 34 - 39
  • [25] Mutations of TET2, IDH1, IDH2 and ASXL1 In Chronic Myeloid Leukemia
    Roche-Lestienne, Catherine
    Alice, Marceau
    Labis, Elise
    Nibourel, Olivier
    Coiteux, Valerie
    Guilhot, Joelle
    Legros, Laurence
    Nicolini, Franck
    Rousselot, Philippe
    Gardembas, Martine
    Helevaut, Nathalie
    Frimat, Cecile
    Guilhot, Francois
    Preudhomme, Claude
    BLOOD, 2010, 116 (21) : 1382 - 1382
  • [26] Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia
    Wang, Jinghan
    Ma, Zhixin
    Wang, Qinrong
    Yu, Mengxia
    Yin, Xiufeng
    Li, Xia
    Suo, Shanshan
    Shen, Dan
    Wang, Yungui
    Huang, Xin
    Pan, Hanzhang
    Wang, Huanping
    Chen, Zhimei
    Huang, Jiansong
    Mao, Liping
    Yu, Wenjuan
    Wei, Juying
    Qian, Wenbin
    Mai, Wenyuan
    Meng, Haitao
    Tong, Hongyan
    Chen, Suning
    Marcucci, Guido
    Chen, Saijuan
    Jin, Jie
    BLOOD, 2016, 128 (22)
  • [27] Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients
    Aref, Salah
    Areida, El Sayed Kamel
    Aaal, Mohamed Fathy Abdel
    Adam, Ola Mohamed
    El-Ghonemy, Mohamed Sabry
    El-Baiomy, Mohamed Ali
    Abou Zeid, Tarek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 550 - 555
  • [28] IDH1 and IDH2 Mutations in Colorectal Cancers
    Huang, Jialing
    Tseng, Li-Hui
    Parini, Vamsi
    Lokhandwala, Parvez M.
    Pallavajjala, Aparna
    Rodriguez, Erika
    Xian, Rena
    Chen, Liam
    Gocke, Christopher D.
    Eshleman, James R.
    Lin, Ming-Tseh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (05) : 777 - 786
  • [29] IDH1 and IDH2 Mutations in Colorectal Cancers
    Lin, M.
    Huang, J.
    Tseng, L.
    Lokhandwala, P.
    Pallavajjala, A.
    Rodriguez, E.
    Xian, R.
    Chen, L.
    Gocke, C.
    Eshleman, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S71 - S71
  • [30] IDH1 AND IDH2 MUTATIONS IN PEDIATRIC OLIGODENDROGLIOMAS
    Hamilton, Ronald
    Pollack, Ian
    NEURO-ONCOLOGY, 2013, 15 : 37 - 37
12345